InDex Pharmaceuticals: Clinical Trials

1 trial sponsored by InDex Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow InDex Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
cobitolimod, Placebo - Ulcerative Colitis
Phase 2CompletedInDex Pharmaceuticals2132017-06-212021-02-01

Conditions studied

Colitis, Ulcerative (1)  ·  Gastrointestinal Diseases (1)  ·  Inflammatory Bowel Diseases (1)

Interventions

cobitolimod (1)

Countries

Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Russia (1)  ·  Serbia (1)  ·  Spain (1)  ·  Sweden (1)  ·  Ukraine (1)

Top investigators

Raja Atreya (1)

Results publications

PMID 33031757

NIH funding

2016 (1)